MALIGNANT NEOPLASM OF OTHER AND UNSPECIFIED SITES (190-199)
- Excludes: carcinoma in situ (234.0-234.9)
- 190 Malignant neoplasm of eye
- Excludes: carcinoma in situ (234.0)
- eyelid (skin) (172.1, 173.1)
- optic nerve (192.0)
- orbital bone (170.0)
- 190.0 Eyeball, except conjunctiva, cornea, retina, and choroid
- Ciliary body
- Crystalline lens
- Iris
- Sclera
- Uveal tract
- 190.1 Orbit
- Connective tissue of orbit
- Extraocular muscle
- Retrobulbar
- Excludes: bone of orbit (170.0)
- 190.2 Lacrimal gland
- 190.3 Conjunctiva
- 190.4 Cornea
- 190.5 Retina
- 190.6 Choroid
- 190.7 Lacrimal duct
- Lacrimal sac
- Nasolacrimal duct
- 190.8 Other specified sites of eye
- Malignant neoplasm of contiguous or overlapping sites of eye whose point of origin cannot be determined
- 190.9 Eye, part unspecified
- 191 Malignant neoplasm of brain
- Excludes: cranial nerves (192.0)
- 191.0 Cerebrum, except lobes and ventricles
- Basal ganglia
- Cerebral cortex
- Corpus striatum
- Globus pallidus
- Hypothalamus
- Thalamus
- 191.1 Frontal lobe
- 191.2 Temporal lobe
- 191.3 Parietal lobe
- 191.4 Occipital lobe
- 191.5 Ventricles
- Choroid plexus
- Floor of ventricle
- 191.6 Cerebellum NOS
- 191.7 Brain stem
- Cerebral peduncle
- Medulla oblongata
- Midbrain
- Pons
- 191.8 Other parts of brain
- Corpus callosum
- Tapetum
- Malignant neoplasm of contiguous or overlapping sites of brain whose point of origin cannot be determined
- 191.9 Brain, unspecified
- 192 Malignant neoplasm of other and unspecified parts of nervous system
- Excludes: peripheral, sympathetic, and parasympathetic nerves and ganglia (171.0-171.9)
- 192.0 Cranial nerves
- 192.1 Cerebral meninges
- Dura (mater)
- Falx (cerebelli) (cerebri)
- Meninges NOS
- Tentorium
- 192.2 Spinal cord
- 192.3 Spinal meninges
- 192.8 Other specified sites of nervous system
- Malignant neoplasm of contiguous or overlapping sites of other parts of nervous system whose point of origin cannot be determined
- 192.9 Nervous system, part unspecified
- Nervous system (central) NOS
- Excludes: meninges NOS (192.1)
- 193 Malignant neoplasm of thyroid gland
- Sipple's syndrome
- Thyroglossal duct
- Use additional code to identify any functional activity
- 194 Malignant neoplasm of other endocrine glands and related structures
- Use additional code to identify any functional activity
- Excludes: islets of Langerhans (157.4)
- ovary (183.0)
- testis (186.0-186.9)
- thymus (164.0)
- 194.0 Adrenal gland
- Adrenal cortex
- Adrenal medulla
- Suprarenal gland
- 194.1 Parathyroid gland
- 194.3 Pituitary gland and craniopharyngeal duct
- Craniobuccal pouch
- Hypophysis
- Rathke's pouch
- Sella turcica
- 194.4 Pineal gland
- 194.5 Carotid body
- 194.6 Aortic body and other paraganglia
- Coccygeal body
- Glomus jugulare
- Para-aortic body
- 194.8 Other
- Pluriglandular involvement NOS
- Note: If the sites of multiple involvements are known, they should be coded separately.
- 194.9 Endocrine gland, site unspecified
- 195 Malignant neoplasm of other and ill-defined sites
- Includes: malignant neoplasms of contiguous sites, not elsewhere classified, whose point of origin cannot be determined
- Excludes: malignant neoplasm:
- lymphatic and hematopoietic tissue (200.0-208.9)
- secondary sites (196.0-198.8)
- unspecified site (199.0-199.1)
- 195.0 Head, face, and neck
- Cheek NOS
- Jaw NOS
- Nose NOS
- Supraclavicular region NOS
- 195.1 Thorax
- Axilla
- Chest (wall) NOS
- Intrathoracic NOS
- 195.2 Abdomen
- 195.3 Pelvis
- Groin
- Inguinal region NOS
- Presacral region
- Sacrococcygeal region
- Sites overlapping systems within pelvis, as:
- rectovaginal (septum)
- rectovesical (septum)
- 195.4 Upper limb
- 195.5 Lower limb
- 195.8 Other specified sites
- Back NOS
- Flank NOS
- Trunk NOS
- 196 Secondary and unspecified malignant neoplasm of lymph nodes
- Excludes: any malignant neoplasm of lymph nodes, specified as primary (200.0-202.9)
- Hodgkin's disease (201.0-201.9)
- lymphosarcoma (200.1)
- reticulosarcoma (200.0)
- other forms of lymphoma (202.0-202.9)
- 196.0 Lymph nodes of head, face, and neck
- Cervical
- Cervicofacial
- Scalene
- Supraclavicular
- 196.1 Intrathoracic lymph nodes
- Bronchopulmonary
- Intercostal
- Mediastinal
- Tracheobronchial
- 196.2 Intra-abdominal lymph nodes
- Intestinal
- Mesenteric
- Retroperitoneal
- 196.3 Lymph nodes of axilla and upper limb
- Brachial
- Epitrochlear
- Infraclavicular
- Pectoral
- 196.5 Lymph nodes of inguinal region and lower limb
- Femoral
- Groin
- Popliteal
- Tibial
- 196.6 Intrapelvic lymph nodes
- Hypogastric
- Iliac
- Obturator
- Parametrial
- 196.8 Lymph nodes of multiple sites
- 196.9 Site unspecified
- 197 Secondary malignant neoplasm of respiratory and digestive systems
- Excludes: lymph node metastasis (196.0-196.9)
- 197.0 Lung
- 197.1 Mediastinum
- 197.2 Pleura
- 197.3 Other respiratory organs
- 197.4 Small intestine, including duodenum
- 197.5 Large intestine and rectum
- 197.6 Retroperitoneum and peritoneum
- 197.7 Liver, specified as secondary
- 197.8 Other digestive organs and spleen
- 198 Secondary malignant neoplasm of other specified sites
- Excludes: lymph node metastasis (196.0-196.9)
- 198.0 Kidney
- 198.1 Other urinary organs
- 198.2 Skin
- 198.3 Brain and spinal cord
- 198.4 Other parts of nervous system
- Meninges (cerebral) (spinal)
- 198.5 Bone and bone marrow
- 198.6 Ovary
- 198.7 Adrenal gland
- 198.8 Other specified sites
- 198.81 Breast
- Excludes: skin of breast (198.2)
- 198.82 Genital organs
- 198.89 Other
- Excludes: retroperitoneal lymph nodes (196.2)
- 199 Malignant neoplasm without specification of site
- 199.0 Disseminated
- Carcinomatosis unspecified site (primary) (secondary)
- Generalized:
- cancer unspecified site (primary) (secondary)
- malignancy unspecified site (primary) (secondary)
- Multiple cancer unspecified site (primary) (secondary)
- 199.1 Other
- Cancer unspecified site (primary) (secondary)
- Carcinoma unspecified site (primary) (secondary)
- Malignancy unspecified site (primary) (secondary)
- MALIGNANT NEOPLASM OF LYMPHATIC AND HEMATOPOIETIC TISSUE (200-208)
- Excludes: secondary neoplasm of:
- bone marrow (198.5)
- spleen (197.8)
- secondary and unspecified neoplasm of lymph nodes (196.0-196.9)
- The following fifth-digit subclassification is for use with categories 200-202:
- 0 unspecified site, extranodal and solid organ sites
- 1 lymph nodes of head, face, and neck
- 2 intrathoracic lymph nodes
- 3 intra-abdominal lymph nodes
- 4 lymph nodes of axilla and upper limb
- 5 lymph nodes of inguinal region and lower limb
- 6 intrapelvic lymph nodes
- 7 spleen
- 8 lymph nodes of multiple sites
- 200 Lymphosarcoma and reticulosarcoma
- Requires fifth digit. See note before section 200 for codes and definitions.
- 200.0 Reticulosarcoma
- Lymphoma (malignant):
- histiocytic (diffuse):
- nodular
- pleomorphic cell type
- reticulum cell type
- Reticulum cell sarcoma:
- NOS
- pleomorphic cell type
- 200.1 Lymphosarcoma
- Lymphoblastoma (diffuse)
- Lymphoma (malignant):
- lymphoblastic (diffuse)
- lymphocytic (cell type) (diffuse)
- lymphosarcoma type
- Lymphosarcoma:
- NOS
- diffuse NOS
- lymphoblastic (diffuse)
- lymphocytic (diffuse)
- prolymphocytic
- Excludes: lymphosarcoma:
- follicular or nodular (202.0)
- mixed cell type (200.8)
- lymphosarcoma cell leukemia (207.8)
- 200.2 Burkitt's tumor or lymphoma
- Malignant lymphoma, Burkitt's type
- 200.8 Other named variants
- Lymphoma (malignant):
- lymphoplasmacytoid type
- mixed lymphocytic-histiocytic (diffuse)
- Lymphosarcoma, mixed cell type (diffuse)
- Reticulolymphosarcoma (diffuse)
- 201 Hodgkin's disease
- Requires fifth digit. See note before section 200 for codes and definitions.
- 201.0 Hodgkin's paragranuloma
- 201.1 Hodgkin's granuloma
- 201.2 Hodgkin's sarcoma
- 201.4 Lymphocytic-histiocytic predominance
- 201.5 Nodular sclerosis
- Hodgkin's disease, nodular sclerosis:
- 201.6 Mixed cellularity
- 201.7 Lymphocytic depletion
- Hodgkin's disease, lymphocytic depletion:
- NOS
- diffuse fibrosis
- reticular type
- 201.9 Hodgkin's disease, unspecified
- Hodgkin's:
- Malignant:
- lymphogranuloma
- lymphogranulomatosis
- 202 Other malignant neoplasms of lymphoid and histiocytic tissue
- Requires fifth digit. See note before section 200 for codes and definitions.
- 202.0 Nodular lymphoma
- Brill-Symmers disease
- Lymphoma:
- follicular (giant)
- lymphocytic, nodular
- Lymphosarcoma:
- follicular (giant)
- nodular
- Reticulosarcoma, follicular or nodular
- 202.1 Mycosis fungoides
- 202.2 Sézary's disease
- 202.3 Malignant histiocytosis
- Histiocytic medullary reticulosis
- Malignant:
- reticuloendotheliosis
- reticulosis
- 202.4 Leukemic reticuloendotheliosis
- 202.5 Letterer-Siwe disease
- Acute:
- differentiated progressive histiocytosis
- histiocytosis X (progressive)
- infantile reticuloendotheliosis
- reticulosis of infancy
- Excludes: Hand-Schüller-Christian disease (277.8)
- histiocytosis (acute) (chronic) (277.8)
- histiocytosis X (chronic) (277.8)
- 202.6 Malignant mast cell tumors
- Malignant:
- Mast cell sarcoma
- Systemic tissue mast cell disease
- Excludes: mast cell leukemia (207.8)
- 202.8 Other lymphomas
- Lymphoma (malignant):
- Excludes: benign lymphoma (229.0)
- 202.9 Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue
- Malignant neoplasm of bone marrow NOS
- 203 Multiple myeloma and immunoproliferative neoplasms
- The following fifth-digit subclassification is for use with category 203:
- 0 without mention of remission
- 1 in remission
- 203.0 Multiple myeloma
- Kahler's disease
- Myelomatosis
- Excludes: solitary myeloma (238.6)
- 203.1 Plasma cell leukemia
- 203.8 Other immunoproliferative neoplasms
- 204 Lymphoid leukemia
- Includes: leukemia:
- lymphatic
- lymphoblastic
- lymphocytic
- lymphogenous
- The following fifth-digit subclassification is for use with category 204:
- 0 without mention of remission
- 1 in remission
- 204.0 Acute
- Excludes: acute exacerbation of chronic lymphoid leukemia (204.1)
- 204.1 Chronic
- 204.2 Subacute
- 204.8 Other lymphoid leukemia
- Aleukemic leukemia:
- lymphatic
- lymphocytic
- lymphoid
- 204.9 Unspecified lymphoid leukemia
- 205 Myeloid leukemia
- Includes: leukemia:
- granulocytic
- myeloblastic
- myelocytic
- myelogenous
- myelomonocytic
- myelosclerotic
- myelosis
- The following fifth-digit subclassification is for use with category 205:
- 0 without mention of remission
- 1 in remission
- 205.0 Acute
- Acute promyelocytic leukemia
- Excludes: acute exacerbation of chronic myeloid leukemia (205.1)
- 205.1 Chronic
- Eosinophilic leukemia
- Neutrophilic leukemia
- 205.2 Subacute
- 205.3 Myeloid sarcoma
- Chloroma
- Granulocytic sarcoma
- 205.8 Other myeloid leukemia
- Aleukemic leukemia:
- granulocytic
- myelogenous
- myeloid
- Aleukemic myelosis
- 205.9 Unspecified myeloid leukemia
- 206 Monocytic leukemia
- Includes: leukemia:
- histiocytic
- monoblastic
- monocytoid
- The following fifth-digit subclassification is for use with category 206:
- 0 without mention of remission
- 1 in remission
- 206.0 Acute
- Excludes: acute exacerbation of chronic monocytic leukemia (206.1)
- 206.1 Chronic
- 206.2 Subacute
- 206.8 Other monocytic leukemia
- Aleukemic:
- monocytic leukemia
- monocytoid leukemia
- 206.9 Unspecified monocytic leukemia
- 207 Other specified leukemia
- Excludes: leukemic reticuloendotheliosis (202.4)
- plasma cell leukemia (203.1)
- The following fifth-digit subclassification is for use with category 207:
- 0 without mention of remission
- 1 in remission
- 207.0 Acute erythremia and erythroleukemia
- Acute erythremic myelosis
- Di Guglielmo's disease
- Erythremic myelosis
- 207.1 Chronic erythremia
- Heilmeyer-Schöner disease
- 207.2 Megakaryocytic leukemia
- Megakaryocytic myelosis
- Thrombocytic leukemia
- 207.8 Other specified leukemia
- Lymphosarcoma cell leukemia
- 208 Leukemia of unspecified cell type
- The following fifth-digit subclassification is for use with category 208:
- 0 without mention of remission
- 1 in remission
- 208.0 Acute
- Acute leukemia NOS
- Blast cell leukemia
- Stem cell leukemia
- Excludes: acute exacerbation of chronic unspecified leukemia (208.1)
- 208.1 Chronic
- 208.2 Subacute
- 208.8 Other leukemia of unspecified cell type
- 208.9 Unspecified leukemia